Loading resource…

Kishan K. Patel, MD, MHS; Alison J. Moskowitz, MD
Hodgkin lymphoma (HL) is a lymphoid malignancy derived from B cells, with Classic HL accounting for 90% to 95% of cases. The review discusses the bimodal age distribution of cHL, common presenting symptoms, and the importance of monitoring for treatment-related complications in survivors. It also highlights the risk factors associated with cHL and the necessity for follow-up care post-treatment.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

HODGKINS AND NON HODGKINS LYMPHOMA (2)
Same specialty · Hematology/Oncology

LYMPHOMAS
Same specialty · Hematology/Oncology

HAEMATOLOGICAL MALIGNANCIES: LEUKEMIAS AND MULTIPLE MYELOMA
Same specialty · Hematology/Oncology

Traumatic Brain Injury
Same resource type · Neurology

ADA Consensus Report: MASLD in People With Diabetes
Same resource type · Endocrinology

Hospital Care for Children Guidelines
Same resource type · Pediatrics

Management of Obesity
Same resource type

Classification of the Epilepsies
Same resource type · Neurology

AOGU Position Statement on Acetaminophen Use in Pregnancy
Same resource type · Obstetrics and Gynecology